DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)



company name or ticker
Company Photos
(Click to zoom)

Amgen (AMGN) Hits New Lifetime High Today

RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now

Techne Corporation (TECH) Ex-Dividend Date Scheduled for August 19, 2014

Nasdaq 100 Movers: NTAP, MNST

Biotech Stock Mailbag: Exact Sciences, Galena, Amgen

Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails - Analyst Blog

Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails - Analyst Blog

Thursday's ETF Movers: BBH, GXC

Today's Market: Biotech And Technology Names Moving On News

Trade-Ideas: Amgen (AMGN) Is Today's "Barbarian At The Gate" Stock

Why Amgen, Inc.’s Kyprolis FOCUS Failure Is a Big Deal

European regulators are going to want to see survival data for Kyprolis.
See More Articles...